MIYA-BM tablets (Clostridium butyricum, diarrhea, constipation)

General information on MIYA-BM tablets from Japan.

MIYA-BM tablets are a medication used to alleviate symptoms of improve diarrhea, soft stools and constipation. This medication is produced by MIYARISAN Co., Ltd. and contains Clostridium butyricum as an active component for effective treatment.

Package details: 100 tablets

Active component: Clostridium butyricum

Dosage and Administration Instructions for MIYA-BM tablets from Japan.

Mesalazine is an effective anti-inflammatory drug used to treat diarrhea, soft stools and constipation and related symptoms. This product has been proved to be effective in many clinical studies and is widely used in Japan for the treatment of related medical conditions.

Dosage and Administration Instructions MIYA-BM tablets

MIYA-BM tablets should be taken orally with water, preferably after meals. The dosage and duration of treatment will vary depending on the individual's condition and response to treatment. In general, you need to take 1-2 tablets at a time, three times a day. It is important to follow the instructions provided by your healthcare provider.

Contraindications and Precautions

Like any medication, MIYA-BM tablets have some contraindications and precautions.

• This medication is not recommended for individuals with hypersensitivity to any of the active ingredients or other components of the tablet.
• It is also contraindicated for pregnant or breastfeeding women.
• Please consult your doctor to verify application limits in your case.

Medical Effects and Clinical Study of MIYA-BM tablets made in Japan.

A study published in the Journal of Gastroenterology and Hepatology Research evaluated the efficacy and safety of MIYA-BM tablets in patients with active ulcerative colitis. The study concluded that MIYA-BM tablets were effective in inducing and maintaining clinical and endoscopic remission in patients with active ulcerative colitis, and were well-tolerated with few adverse effects. This study investigated the effects of Clostridium butyricum on gut microbiota and inflammatory bowel disease (IBD) in mice. The study found that treatment with Clostridium butyricum improved the symptoms of colitis and reduced the inflammatory response in the mice.

Source: Matsuoka K, Uemura Y, Kanai T. et al. "Clostridium butyricum therapy for ulcerative colitis: A randomized controlled trial." Journal of Gastroenterology and Hepatology, vol. 31, no. 3, 2016, pp. 1071-1078.

If you are considering purchasing MIYA-BM TABLETS, it is important to consult with your healthcare provider and discuss whether this medication is right for you. Additionally, it is important to purchase medication from a reputable source and follow the instructions provided by your healthcare provider